Skip to content

Clinical trials

Phase 3 Brain Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Neoplasms Phase: Phase 3 Country / region: United States Clear all

69 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20023
20048
20052
20064
20073
20084
20095
20112
20121
20152
20164
20173
20184
20191
20201
20215
20223
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed38
Active, not recruiting12
Terminated8
Recruiting6
Unknown status3
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center6
Children's Oncology Group5
NRG Oncology5
Alliance for Clinical Trials in Oncology4
Celtic Pharma Development Services3
Bristol-Myers Squibb2
INSYS Therapeutics Inc2
National Cancer Institute (NCI)2
NovoCure Ltd.2
Pharmacyclics LLC.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Neoplasms69
Glioblastoma20
Astrocytoma14
Neoplasm Metastasis14
Glioma13
Central Nervous System Neoplasms10
Breast Neoplasms9
Carcinoma, Non-Small-Cell Lung8
Gliosarcoma8
Neoplasms8

Trials

Showing 1 to 25 of 69. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.